Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 15, 2025

Primary Completion Date

April 15, 2027

Study Completion Date

December 15, 2027

Conditions
Obesity &Amp; OverweightDigestive Disorders
Interventions
DIETARY_SUPPLEMENT

Probiotics (Natural product)

"Participants will be instructed to daily take, during 26 weeks (that will begin 2 weeks before the initiation of semaglutide or tirzepatide treatment) one capsule of a probiotic with water at room temperature with the first meal.~Dosage levels: 1 capsule Digestive Quality of life during the study will be assessed."

OTHER

Placebo

"Participants will be instructed to daily take, during 26 weeks (that will begin 2 weeks before the initiation of semaglutide or tirzepatide treatment) one capsule of PLACEBO with water at room temperature with the first meal.~Digestive Quality of life during the study will be assessed."

Trial Locations (1)

69495

Hôpital Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT07213323 - Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment | Biotech Hunter | Biotech Hunter